The Identification of Trans-acting Factors That Regulate the Expression of GDF5 via the Osteoarthritis Susceptibility SNP rs143383

PLoS Genetics

Volumn 9, Issue 6, 2013, Pages

  Syddall, Catherine M ^a   Reynard, Louise N ^a   Young, David A ^a   Loughlin, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1; GROWTH DIFFERENTIATION FACTOR 5; PROTEIN P15; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MASS SPECTROMETRY; OSTEOARTHRITIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RISK FACTOR; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ALLELES; ALLELIC IMBALANCE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GROWTH DIFFERENTIATION FACTOR 5; HUMANS; NUCLEAR PROTEINS; OSTEOARTHRITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

EID: 84879671961     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003557     Document Type: Article

References (58)

1. Brandt KD, Dieppe P, Radin E, (2008) Etiopathogenesis of osteoarthritis. Rheum Dis Clin North Am 34: 531-559.
2. Nüesch E, Dieppe P, Reichenbach S, Williams S, Iff S, et al. (2011) All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 342: d1165.
3. Burrage PS, Brinckerhoff CE, (2007) Molecular Targets in osteoarthritis: metalloproteinases and their inhibitors. Curr Drug Targets 8: 293-303.
4. Spector TD, MacGregor AJ, (2004) Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage 12: 39-44.
5. arcOGEN Consortium and arcOGEN Collaborators (2012) Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association scan. Lancet 380: 815-823.
6. Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, et al. (2007) A functional polymorphism in the 5′UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 39: 529-533.
7. Southam L, Rodriguez-Lopez J, Wilkins JM, Pombo-Suarez M, Snelling S, et al. (2007) An SNP in the 5′-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum Mol Genet 16: 2226-2232.
8. Chapman K, Takahashi A, Meulenbelt I, Watson C, Rodriguez-Lopez J, et al. (2008) A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5′ UTR of GDF5 with osteoarthritis susceptibility. Hum Mol Genet 17: 1497-1504.
9. Egli R, Southam L, Wilkins JM, Lorenzen I, Pombo-Suarez M, et al. (2009) Functional analysis of the GDF5 regulatory polymorphism that is associated with OA susceptibility. Arthritis Rheum 60: 2055-2064.
10. Francis-West PH, Abdelfattah A, Chen P, Allen C, Parish J, et al. (1999) Mechanisms of GDF-5 action during skeletal development. Development 126: 1305-1315.
11. Hotten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, et al. (1996) Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13: 65-74.
12. Chhabra A, Tsou D, Clark RT, Gaschen V, Hunziker EB, et al. (2003) GDF-5 deficiency in mice delays Achilles tendon healing. J Orthop Res 21: 826-835.
13. Chhabra A, Zijerdi D, Zhang J, Kline A, Balian G, et al. (2005) BMP-14 deficiency inhibits long bone fracture healing: a biochemical, histologic, and radiographic assessment. J Orthop Trauma 19: 629-634.
14. Erlacher L, Ng CK, Ullrich R, Krieger S, Luyten FP, (1998) Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum 41: 263-273.
15. Rickert M, Wang H, Wieloch P, Lorenz H, Steck E, et al. (2005) Adenovirus-mediated gene transfer of growth and differentiation factor-5 into tenocytes and the healing rat Achilles tendon. Connect Tissue Res 46: 175-183.
16. Tashiro T, Hiraoka H, Ikeda Y, Ohnuki T, Suzuki R, et al. (2006) Effect of GDF-5 on ligament healing. J Orthop Res 24: 71-79.
17. Polinkovsky A, Robin NH, Thomas JT, Irons M, Lynn A, et al. (1997) Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 17: 18-19.
18. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, et al. (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17: 58-64.
19. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, et al. (1996) A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nat Genet 12: 315-317.
20. Yang W, Cao L, Liu W, Jiang L, Sun M, et al. (2008) Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism. J Hum Genet 53: 368-374.
21. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, et al. (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF β-superfamily. Nature 368: 639-643.
22. Daans M, Luyten FP, Lories RJ, (2011) GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis 70: 208-213.
23. Reynard LN, Bui C, Canty-Laird EG, Young DA, Loughlin J, (2011) Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 20: 3450-3460.
24. Kingsley C, Winoto A, (1992) Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Bio 12: 4251-4261.
25. Kaczynski J, Cook T, Urrutia R, (2003) Sp1- and Kruppel-like transcription factors. Genome Biol 4: 206-214.
26. Zaid A, Hodny Z, Li R, Nelson BD, (2001) Sp1 acts as a repressor of the human adenine nucleotide translocase-2 (ANT2) promoter. Eur J Bioch 268: 5497-5503.
27. Zhang Y, Dufau ML, (2003) Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol Cell Biol 23: 6958-6972.
28. Majello B, De Luca P, Lania L, (1997) Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem 272: 4021-4026.
29. Zhang X, Li Y, Dai C, Yang J, Mundel P, et al. (2003) Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am J Physiol 284: 82-94.
30. Pugh BF, Tjian R, (1991) Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev 5: 1935-1945.
31. Pascal E, Tjian R, (1991) Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5: 1646-1656.
32. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, et al. (1999) Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19: 5504-5511.
33. Krüger I, Vollmer M, Simmons D, Elsässer HP, Philipsen S, et al. (2007) Sp1/Sp3 compound heterozygous mice are not viable: Impaired erythropoiesis and severe placental defects. Dev Dyn 236: 2235-2244.
34. Beauchef G, Bigot N, Kypriotou M, Renard E, Poree BT, et al. (2012) The p65 subunit of NF-kB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3). J Biol Chem 287: 3462-3478.
35. Zhang Y, Hassan MQ, Xie RL, Hawse JR, Spelsberg TC, et al. (2009) Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats). J Biol Chem 284: 3125-3135.
36. Piera-Velazquez S, Hawkins DF, Whitecavage MK, Colter DC, Stokes DG, et al. (2007) Regulation of the human SOX9 promoter by Sp1 and CREB. Exp Cell Res 313: 1069-1079.
37. Conesa C, Acker J, (2010) Sub1/PC4 a chromatin associated protein with multiple functions in transcription. RNA Biol 7: 287-290.
38. Ge H, Roeder RG, (1994) Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 78: 513-523.
39. Ge H, Si Y, Wolffe AP, (1998) A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol Cell 2: 751-759.
40. Liao M, Zhang Y, Kang JH, Dufau ML, (2011) Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription. J Biol Chem 286: 7681-7691.
41. Malik S, Guermah M, Roeder RG, (1998) A dynamic model for PC4 coactivator function in RNA polymerase II transcription. Proc Natl Acad Sci USA 95: 2192-2197.
42. Huggenvik JI, Michelson RJ, Collard MW, Ziemba AJ, Gurley P, et al. (1998) Characterization of a nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related (NUDR) transcriptional regulator protein. Mol Endocrinol 12: 1619-1639.
43. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, et al. (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23: 8788-8799.
44. Czesak M, Lemonde S, Peterson EA, Rogaeva A, Albert PR, (2006) Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 26: 1864-1871.
45. Hahm K, Sum EY, Fujiwara Y, Lindeman GJ, Visvader JE, et al. (2004) Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol Cell Biol 24: 2074-2082.
46. Dodd AW, Syddall CM, Loughlin J, (2012) A rare variant in the osteoarthritis-associated locus GDF5 is functional and reveals a site that can be manipulated to modulate GDF5 expression. Eur J Hum Genetics (in press) doi: 10.1038/ejhg.2012.197.
47. Lescuyer P, Martinez P, Lunardi J, (2002) YY1 and Sp1 activate transcription of the human NDUFS8 gene encoding the mitochondrial complex I TYKY subunit. Biochim Biophys Acta 1574: 164-174.
48. Dai J, Shi D, Zhu P, Qin J, Ni H, et al. (2008) Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res Ther 10: R126.
49. Posthumus M, Collins M, Cook J, Handley CJ, Ribbans WJ, et al. (2010) Components of the transforming growth factor-β family and the pathogenesis of human Achilles tendon pathology-a genetic association study. Rheumatology (Oxford) 49: 2090-2097.
50. Williams FMK, Popham M, Hart DJ, de Schepper E, Bierma-Zeinstra S, et al. (2011) GDF5 single-nucleotide polymorphism rs143383 is associated with lumbar disc degeneration in Northern European women. Arthritis Rheum 63: 708-712.
51. Sanna S, Jackson AU, Nagaraja R, Willer CJ, Chen WM, et al. (2008) Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet 40: 198-203.
52. Vaes RBA, Rivadeneira F, Kerkhof JM, Hofman A, Pols HAP, et al. (2008) Genetic variation in the GDF5 region is associated with osteoarthritis, height, hip axis length and fracture risk: the Rotterdam study. Ann Rheum Dis 68: 1754-1760.
53. Brennan P, Donev R, Hewamana S, (2008) Targeting transcription factors for therapeutic benefit. Mol BioSyst 4: 909-919.
54. Borgatti M, Boyd DD, Lampronti I, Bianchi N, Fabbri E, et al. (2005) Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol Res 15: 373-383.
55. Rowan AD, Koshy PJ, Shingleton WD, Degnan BA, Heath JK, et al. (2001) Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 44: 1620-1632.
56. Reed DE, Huang XM, Wohlschlegel JA, Levine MS, Senger K, (2008) DEAF-1 regulates immunity gene expression in Drosophila. Proc Natl Acad Sci USA 105: 8351-8356.
57. Vivancos P D, Driscoll SP, Bulman CA, Ying L, Emami K, (2011) Perturbations of amino acid metabolism associated with glyphosate-dependent inhibition of shikimic acid metabolism affect cellular redox homeostasis and alter the abundance of proteins involved in photosynthesis and photorespiration. Plant Physiol 157: 256-268.
58. Yip L, Su L, Sheng D, Chang P, Atkinson M, et al. (2009) Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 10: 1026-1033.